Testing the Addition of M3814 (Peposertib) to Radiation Therapy for Patients With Advanced Head and Neck Cancer Who Cannot Take Cisplatin
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Pfizer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Dragonfly Therapeutics
Boehringer Ingelheim
National Cancer Institute (NCI)
Stanford University
University of Colorado, Denver
Seagen Inc.
Johnson & Johnson Enterprise Innovation Inc.
Exelixis
University of California, Davis
Kivu Bioscience Inc.
Vanderbilt-Ingram Cancer Center
EpiBiologics
Fox Chase Cancer Center
AstraZeneca
University of Chicago
Pfizer
Boehringer Ingelheim
Emory University
Aktis Oncology, Inc.
M.D. Anderson Cancer Center
University College, London
AstraZeneca
ViroMissile, Inc.
EMD Serono
Dana-Farber Cancer Institute
Arcus Biosciences, Inc.
Erasca, Inc.
R-Pharm
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Radiopharm Theranostics, Ltd
M.D. Anderson Cancer Center
Seagen Inc.
Bayer
Pfizer
AstraZeneca
Pfizer
Pfizer